نتائج البحث - "Adnan Khattak"

1

BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?

المؤلفون: Jeanne Tie, Jayesh Desai, Simone Steel, Vanessa Wong, Jeremy Shapiro, Margaret Lee, Peter Gibbs, Adnan Khattak, Rachel Wong, Wei Hong, Matthew Burge, Brigette B.Y. Ma, Louise M. Nott

المصدر: Targeted Oncology. 16:227-236

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::22f7d7e129140a629988bd9957af1d94Test
https://doi.org/10.1007/s11523-021-00793-7Test

2

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

المساهمون: CCA - Cancer Treatment and quality of life, Medical oncology

المصدر: Journal of Clinical Oncology, 38, 3925-3936
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, di Giacomo, A M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P C, van Akkooi, A C J, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2020, ' Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial ', Journal of Clinical Oncology, vol. 38, no. 33, pp. 3925-3936 . https://doi.org/10.1200/JCO.20.02110Test
Journal of Clinical Oncology, 38(33), 3925-3936. American Society of Clinical Oncology
Journal of Clinical Oncology
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, A M, van den Eertwegh, A J M, Grob, J J, Gutzmer, R, Jamal, R, Lorigan, P C, van Akkooi, A C J, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2020, ' Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma : Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, no. 33, pp. 3925-3936 . https://doi.org/10.1200/JCO.20.02110Test
Journal of Clinical Oncology, 38, 33, pp. 3925-3936

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Medizin, Pembrolizumab, Placebo, law.invention, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Original Reports, medicine, Stage III melanoma, Melanoma, Chemotherapy, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Cancer, medicine.disease, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, business, Adjuvant

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c8d8800862ec580f808001677c9a85Test
https://hdl.handle.net/2066/228545Test

3

Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer

المصدر: Current problems in cancer. 46(2)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f0ed897b07bcfd6a00b30a5592c890dTest
https://pubmed.ncbi.nlm.nih.gov/34565601Test

4

Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

المساهمون: Medical oncology, CCA - Cancer biology and immunology, CCA - Cancer Treatment and quality of life, AII - Cancer immunology

المصدر: Ann Transl Med
European Journal of Cancer, 116, pp. 148-157
European Journal of Cancer, 116, 148-157. Pergamon
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A, Lichinitser, M, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, di Giacomo, A M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P C, Lupinacci, R, Krepler, C, Ibrahim, N, Kicinski, M, Marreaud, S, van Akkooi, A C, Suciu, S & Robert, C 2019, ' Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma ', European Journal of Cancer, vol. 116, pp. 148-157 . https://doi.org/10.1016/j.ejca.2019.05.020Test
European Journal of Cancer, 116, 148-157

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Skin Neoplasms, medicine.medical_treatment, Medizin, Pembrolizumab, Metastasis, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 0302 clinical medicine, Antineoplastic Agents, Immunological, Adjuvant therapy, AJCC-7, AJCC-8, EORTC 1325/KN-054, Melanoma, Phase III trial, Predictive factors, Prognostic factors, Adult, Aged, Antibodies, Monoclonal, Humanized, Disease-Free Survival, Double-Blind Method, Female, Humans, Middle Aged, Neoplasm Staging, Prognosis, Treatment Outcome, Monoclonal, Humanized, Hazard ratio, Editorial Commentary, Immunological, 030220 oncology & carcinogenesis, medicine.drug, medicine.medical_specialty, Antineoplastic Agents, Ipilimumab, Antibodies, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Internal medicine, medicine, business.industry, Cancer, medicine.disease, 030104 developmental biology, Lymphadenectomy, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0e8c4fb38d782241aa3a6b2f75643c8Test
https://hdl.handle.net/2066/206244Test

5

Delayed immune-related adverse events with anti-PD1-based immunotherapy in melanoma

المساهمون: Faculty of Sciences and Bioengineering Sciences, Laboratory for Medical and Molecular Oncology, Clinical sciences, Medical Oncology, Faculty of Psychology and Educational Sciences, Physics

المصدر: Owen, C N, Bai, X, Quah, T, Lo, S N, Allayous, C, Callaghan, S, Martínez-Vila, C, Wallace, R, Bhave, P, Reijers, I L M, Thompson, N, Vanella, V, Gerard, C L, Aspeslagh, S, Labianca, A, Khattak, A, Mandala, M, Xu, W, Neyns, B, Michielin, O, Blank, C U, Welsh, S J, Haydon, A, Sandhu, S, Mangana, J, McQuade, J L, Ascierto, P A, Zimmer, L, Johnson, D B, Arance, A, Lorigan, P, Lebbé, C, Carlino, M S, Sullivan, R J, Long, G V & Menzies, A M 2021, ' Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma ', Annals of Oncology, vol. 32, no. 7, pp. 917-925 . https://doi.org/10.1016/j.annonc.2021.03.204Test

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13b5c19117384b568cfd2a11dbc3489cTest
http://hdl.handle.net/11391/1491436Test

6

Reply to E. Hindié

المصدر: Journal of Clinical Oncology, 39, 8, pp. 944-946
Journal of Clinical Oncology, 39, 944-946

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c843a2657530330474a766f083b07e20Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85102657696Test

7

Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status

المصدر: Clinical colorectal cancer. 20(1)

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Time Factors, Adolescent, Colorectal cancer, Population, Kaplan-Meier Estimate, Systemic therapy, Risk Assessment, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Registries, Karnofsky Performance Status, education, Colectomy, Aged, Retrospective Studies, Aged, 80 and over, education.field_of_study, Proportional hazards model, business.industry, Gastroenterology, Middle Aged, medicine.disease, Comorbidity, Progression-Free Survival, Oxaliplatin, Tumor Burden, Clinical trial, Oncology, Fluorouracil, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Female, business, Colorectal Neoplasms, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcb92697007a2d9518b81a76a5b5473aTest
https://pubmed.ncbi.nlm.nih.gov/32919889Test

8

1678P_PR The impact of COVID-19 pandemic on cancer care: A global collaborative study

المؤلفون: Mohammad Alkaiyat, Adnan Khattak, A. A. Alsharm, Hakan Akbulut, Giuseppe Curigliano, Hassan Errihani, Abdul Rahman Jazieh, Christian Rolfo, R.B. De Guzman, E. Razis, Álvaro Rogado, Hoda Jradi, L.Y.I. Mula-Hussain, C. Mathias

المصدر: Annals of Oncology

مصطلحات موضوعية: medicine.medical_specialty, Oncology, Coronavirus disease 2019 (COVID-19), business.industry, Family medicine, Pandemic, Medicine, Cancer, Hematology, business, medicine.disease, Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91926fedf2431219271ea7da8eee9d05Test
https://doi.org/10.1016/j.annonc.2020.08.2325Test

9

Genomic HLA heterozygosity as a predictive marker for survival in lung cancer patients post immunotherapy

المؤلفون: Adnan Khattak, Abha Chopra, Michael Millward, A. Abed, Elin S. Gray

المصدر: Annals of Oncology. 30:ix194

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Multivariate analysis, Predictive marker, business.industry, medicine.medical_treatment, Hematology, Human leukocyte antigen, Immunotherapy, medicine.disease, Loss of heterozygosity, symbols.namesake, Internal medicine, symbols, Medicine, Neutrophil to lymphocyte ratio, business, Lung cancer, Fisher's exact test

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0b345a5a8ae95a7929c3e4c44964d144Test
https://doi.org/10.1093/annonc/mdz446.013Test

10

Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study

المؤلفون: Filippo de Marinis, Amparo Valladares, Dae Ho Lee, Smita Kothari, Adnan Khattak, Javier de Castro, Ming Shyan Huang, Ming-Sound Tsao, Hiroshi Isobe, Ashwini Arunachalam, Xiting Cao, Carlos Barrios, Karl Otto Kambartel, Thomas Burke

المصدر: PLoS ONE, Vol 13, Iss 8, p e0202865 (2018)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

مصطلحات موضوعية: Oncology, Male, Lung Neoplasms, medicine.medical_treatment, lcsh:Medicine, Targeted therapy, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Anaplastic lymphoma kinase, 030212 general & internal medicine, Practice Patterns, Physicians', lcsh:Science, Aged, 80 and over, Multidisciplinary, medicine.diagnostic_test, Middle Aged, Prognosis, humanities, Europe, Survival Rate, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, Brazil, Adult, medicine.medical_specialty, Asia, Context (language use), 03 medical and health sciences, Internal medicine, medicine, Carcinoma, Biomarkers, Tumor, Humans, Genetic Testing, Lung cancer, Survival rate, Genetic testing, Aged, Retrospective Studies, business.industry, lcsh:R, Australia, Retrospective cohort study, medicine.disease, respiratory tract diseases, Mutation, lcsh:Q, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38d2625549b4b24fa8aa5fef1f7f5f95Test
http://europepmc.org/articles/PMC6110501?pdf=renderTest

تنقيح النتائج